The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
McKeown-Longo, Paula J.
Funding for this research was provided by:
National Institutes of Health (CA058626)
U.S. Department of Defense (LC090169)
unspecified valid from 2016-08-02